Please check your internet connection and try again.
# Sompraz hp
## Overview
Sompraz hp is a combination medication containing **esomeprazole** (a proton pump inhibitor or PPI) and **amoxicillin** and **clarithromycin** (antibiotics). It is used to eradicate *Helicobacter pylori* infection.
## Primary Indications
* Treatment of *Helicobacter pylori* infection in patients with peptic ulcer disease or a history of peptic ulcer disease.
## Adult Dosing
The typical regimen is one packet twice daily for 10 days. Each packet contains:
* Esomeprazole 20 mg
* Amoxicillin 1000 mg
* Clarithromycin 500 mg
**Maximum Dose:** Not established for the combination product. Individual component maximums should be considered:
* Esomeprazole: Generally 40 mg daily.
* Amoxicillin: Generally 4000 mg daily in divided doses for severe infections.
* Clarithromycin: Generally 1000 mg twice daily.
## Pediatric Dosing
Specific pediatric dosing for Sompraz hp is not established. Dosing for individual components in children varies by weight and indication and should be determined by a pediatrician.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment for esomeprazole is generally needed. Significant renal impairment may require dose adjustment for amoxicillin and clarithromycin; consult specific drug information.
* **Hepatic Impairment:** For esomeprazole, consider reducing the dose (e.g., 20 mg once daily). Amoxicillin and clarithromycin generally do not require dose adjustment in mild to moderate hepatic impairment, but caution is advised. Severe hepatic impairment may necessitate dose adjustments for all components.
## Contraindications
* Known hypersensitivity to any component of the medication.
* History of allergic reactions to penicillins, cephalosporins, or other beta-lactam antibiotics.
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Concomitant use with cisapride, ergotamine, ergonovine, methylergonovine, or pimozide due to potential for serious, life-threatening reactions.
* Patients with a genetic predisposition to QT prolongation or ventricular arrhythmias.
* Electrolyte disturbances (e.g., hypokalemia, hypomagnesemia).
## Adverse Effects
**Common:**
* Diarrhea
* Nausea
* Abdominal pain
* Headache
* Dyspepsia
* Taste disturbance (metallic taste)
* Rash
* Vomiting
**Serious:**
* Allergic reactions (anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis)
* *Clostridium difficile*-associated diarrhea (CDAD)
* QT prolongation (especially with clarithromycin)
* Hepatotoxicity
* Bone fractures (with long-term PPI use)
* *Lupus-like syndrome*
## Key Drug Interactions
* **Clarithromycin:** Inhibits CYP3A4. Increases concentrations of:
* Colchicine
* Certain statins (e.g., simvastatin, lovastatin)
* Warfarin
* Theophylline
* Carbamazepine
* Ciclosporin
* Tacrolimus
* Sildenafil
* Calcium channel blockers (e.g., verapamil, diltiazem)
* Anticoagulants (e.g., dabigatran)
* **Esomeprazole:** Inhibits CYP2C19 and CYP3A4. Can affect absorption and/or levels of:
* Antiretrovirals (e.g., rilpivirine, atazanavir)
* Clopidogrel (reduced efficacy)
* Methotrexate
* Voriconazole
* Ketoconazole, itraconazole, posaconazole (reduced absorption)
* **Amoxicillin:** May decrease the efficacy of oral contraceptives.
* **Food:** May decrease the absorption of esomeprazole; however, the combination packet is designed for administration with food to enhance tolerability.
## Monitoring
* Signs and symptoms of *H. pylori* eradication (e.g., resolution of ulcer symptoms).
* Monitor for signs and symptoms of hypersensitivity reactions.
* Monitor for severe diarrhea or signs of *C. difficile* infection.
* Periodic assessment of liver function, especially with prolonged use or in patients with hepatic impairment.
* Monitor for QT interval prolongation, especially in patients with risk factors.
## Clinical Pearls
* This combination therapy aims to simplify the treatment regimen for *H. pylori* eradication.
* Administer each dose with a full glass of water, preferably with food.
* Patients should complete the full 10-day course of therapy, even if they feel better.
* Discontinue therapy and seek medical attention if rash, severe diarrhea, or signs of allergic reaction occur.
* Patients should be advised about potential drug interactions, particularly with other medications they may be taking.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions.
